Combined Usage of Navitoclax and A-1210477 to Treat AcuteLymphoblastic Leukemia
DOI:
https://doi.org/10.61173/pkrxz397Keywords:
Navitoclax, A-1210477, Mcl-1 protein, Bcl-2 protein, Acute Lymphoblastic LeukemiaAbstract
Mcl-1 protein has been a key targeted therapeutic protein in treating acute lymphoblastic leukemia because of its
resistance to other previously known drugs. However, a newly synthesized chemical A-1210477 has proven to possess
enough affinity to bind to the Mcl-1 protein and disrupt its normal function. As a result, scientists started to test the
potency of A-1210477 combined with other drugs to treat various cancers. This study will examine the effect of
A-1210477 and Bcl-2 inhibitor navitoclax combined to treat acute lymphoblastic leukemia Bal-KHc cell line both in
vitro by MTT and Annexin V/PI Facs as well as in vivo by measuring the tumor volume in xenograft.
References
[1] Liu, J., Yu, C., Fan, F., Bao, T., & Chen, D. (2020). The Anticancer Effects of Atractylenolide III Associate With the Downregulation of Jak3_Stat3-Dependent IDO Expression. Frontiers in Pharmacology. https://doi.org/10.3389/ fphar.2019.01505
[2] Lohneis, P., & Quaas, A. (2021). Expression of Immune Checkpoint Regulators IDO, VISTA, LAG3, and TIM3 in Resected Pancreatic Ductal Adenocarcinoma. Cancers. https:// doi.org/10.3390/cancers13112689
[3] Chen, W. (2011). IDO: more than an enzyme. Nature. https:// doi.org/10.1038/ni.2088
[4] Rothman, P., & Tau, G. (1999). Biologic functions of the IFN‐γ receptors. PubMed Central. https://doi.org/10.1034/ j.1398-9995.1999.00099.x
[5] Jan VilčekJunming, L. (1998). Encyclopedia of Immunology ((Second Edition) ed.). San Diego: Academic Press.
[6] Decker, T., Kovarik, P., & Meinke, A. (1997). GAS elements: a few nucleotides with a major impact on cytokine-induced gene expression. PubMed Central. https://doi.org/10.1089/ jir.1997.17.121
[7] The Agency for Science, Technology and Research (A*STAR). (2015, October 1). Removing genes without a trace: DNA repair mechanism manipulated to delete genes without leaving a scar. ScienceDaily. Retrieved July 20, 2022 from www. sciencedaily.com/releases/2015/10/151001151146.htm Dean&Francis
[8] Tessitore, A. A. R. F. L. F. A. G. S. M., Pastore, L., Rispoli, A., Cilenti, L., Toniato, E., Flati, V., Farina, A., Frati, L., Gulino, A., & Martinotti, S. (1998). Two gamma-interferon-activation sites (GAS) on the promoter of the human intercellular adhesion molecule (ICAM-1) gene are required for induction of transcription by IFN-gamma. PubMed. https://doi.org/10.1046/ j.1432-1327.1998.2580968.x
[9] Jiang Y, Chen B, Duan C, Sun B, Yang J, Yang S. Appl Environ Microbiol. 2015 Jan 30. pii: AEM.04023-14. 10.1128/ AEM.04023-14 PubMed 2563838
[10] Kandarian SC, Nosacka RL, Delitto AE, Judge AR, Judge SM, Ganey JD, Moreira JD, Jackman RW. Tumourderived leukaemia inhibitory factor is a major driver of cancer cachexia and morbidity in C26 tumour-bearing mice. J Cachexia Sarcopenia Muscle. 2018 Sep 30. doi: 10.1002/jcsm.12346.
Downloads
Published
Issue
Section
License
Copyright (c) 2023 by the authors.
This work is licensed under a Creative Commons Attribution 4.0 International License.
